Lilly’s retatrutide shows greater efficacy than Ozempic in trial

Earnings call transcript: BASF beats Q3 2026 estimates, narrows outlook

Investing.com · News 7m ago

StrongPoint Q3 2026 slides: revenue jumps 14%, recurring base slips

Investing.com · News 8m ago

Why is F5 stock sliding today?

Investing.com · News 8m ago

This hospice services stock is outperforming the S&P 500. Jefferies sees more gains ahead

CNBC · Economy 9m ago

JPMorgan reiterates ArcelorMittal stock rating on earnings outlook

Investing.com · News 10m ago

Oppenheimer downgrades Enphase Energy stock rating on weak demand

Investing.com · News 10m ago

Jio’s Blockbuster I.P.O. Gives India’s Investors a Lift

The New York Times · Business 10m ago

The ‘Buy, Borrow and Die’ Wealth Strategy Gains in Popularity

Dow Jones · Markets 11m ago

GE Vernova to Buy High-Voltage Grid Equipment Manufacturer for $9 Billion

Dow Jones · Markets 12m ago

Vertiv Raises 2026 Guidance

NASDAQ · Markets 12m ago